Latest Earnings Results: Q2 '26
Estimated EPS
$0.07
Reported EPS
$0.07
Surprise
-4.55%
Estimated Rev
$16.54M
Reported Rev
$17.11M
Surprise
+3.42%
• Reported GAAP EPS of $0.07 up 40.00% YoY • Reported revenue of $17.11M up 35.43% YoY • BrainsWay now expects full-year 2026 revenue of $68 million to $70 million, operating income between 13.5% and 14% of revenue, and Adjusted EBITDA of $13 million to $14 million for the period.
Bullish Takeaway
BrainsWay achieved record system shipments and significant margin expansion during the quarter, supported by strong clinical data and continued growth in the installed base for its proprietary Deep TMS technology.
Bearish Takeaway
BrainsWay faces material risks including potential competitive technology disruption, reliance on third-party payer reimbursement, and the ongoing challenge of retaining key personnel essential to the development of Deep TMS products.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.09 | -- | -- | N/A |
Q2 '26 | $0.07 | $0.07 | -4.55% | MISSED |
Q1 '26 | $0.03 | $0.03 | -- | EXPECTED |
Q4 '25 | $0.03 | $0.07 | 124.84% | BEAT |
Q3 '25 | $0.05 | $0.02 | -57.14% | MISSED |